Combination chemotherapy could prolong the survival of pancreatic cancer patients after surgery
Combination chemotherapy was more effective than single-agent chemotherapy in prolonging the survival of people with pancreatic cancer, according to a trial presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in...